Role of race in oncogenic driver prevalence and outcomes in lung adenocarcinoma: Results from the Lung Cancer Mutation Consortium Academic Article uri icon

Overview

MeSH Major

  • Adenocarcinoma
  • Brain Neoplasms
  • Ethnic Groups
  • Liver Neoplasms
  • Lung Neoplasms

abstract

  • Differences were observed in the prevalence of oncogenic drivers in lung adenocarcinomas and in subsequent treatments among racial groups. The lowest frequency of drivers was seen for AA patients; however, more than half of AA patients had a driver, and those treated with targeted therapy had outcomes similar to those of other races. Cancer 2016;122:766-772. © 2015 American Cancer Society.

publication date

  • March 2016

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC5038591

Digital Object Identifier (DOI)

  • 10.1002/cncr.29812

PubMed ID

  • 26695526

Additional Document Info

start page

  • 766

end page

  • 72

volume

  • 122

number

  • 5